A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
allergic 13 21 13 21 O
reactions 22 31 22 31 O
attributed 32 42 32 42 O
to 43 45 43 45 O
compounds 46 55 46 55 O
of 56 58 56 58 O
similar 59 66 59 66 O
chemical 67 75 67 75 O
or 76 78 76 78 O
biologic 79 87 79 87 O
composition 88 99 88 99 O
to 100 102 100 102 O
dexrazoxane 103 114 103 114 B-allergy_name
or 115 117 115 117 O
other 118 123 118 123 O
agents 124 130 124 130 O
used 131 135 131 135 O
in 136 138 136 138 O
the 139 142 139 142 O
study 143 148 143 148 O

AST(SGOT)/ALT(SGPT 0 18 149 167 B-clinical_variable
) 18 19 167 168 I-clinical_variable
≤ 20 21 169 170 O
3.0 22 25 171 174 B-upper_bound
x 26 27 175 176 I-upper_bound
IULN 28 32 177 181 I-upper_bound

Absolute 0 8 182 190 B-clinical_variable
neutrophil 9 19 191 201 I-clinical_variable
count 20 25 202 207 I-clinical_variable
≥ 26 27 208 209 O
1,500 28 33 210 215 B-lower_bound
/ 33 34 215 216 I-lower_bound
mcl 34 37 216 219 I-lower_bound

Angiosarcoma 0 12 220 232 B-cancer

Appropriate 0 11 233 244 O
studies 12 19 245 252 O
will 20 24 253 257 O
be 25 27 258 260 O
undertaken 28 38 261 271 O
in 39 41 272 274 O
patients 42 50 275 283 O
receiving 51 60 284 293 O
combination 61 72 294 305 O
antiretroviral 73 87 306 320 B-treatment
therapy 88 95 321 328 I-treatment
when 96 100 329 333 O
indicated 101 110 334 343 O

At 0 2 344 346 O
least 3 8 347 352 O
18 9 11 353 355 B-lower_bound
years 12 17 356 361 I-lower_bound
of 18 20 362 364 O
age 21 24 365 368 B-age

Creatinine 0 10 369 379 B-clinical_variable
≤ 11 12 380 381 O
IULN 13 17 382 386 O
OR 18 20 387 389 O
Creatinine 21 31 390 400 B-clinical_variable
clearance 32 41 401 410 I-clinical_variable
≥ 42 43 411 412 O
60 44 46 413 415 B-lower_bound
mL 47 49 416 418 I-lower_bound
/ 49 50 418 419 I-lower_bound
min/1.73 50 58 419 427 I-lower_bound
m^2 59 62 428 431 I-lower_bound
for 63 66 432 435 O
patients 67 75 436 444 O
with 76 80 445 449 O
creatinine 81 91 450 460 B-clinical_variable
levels 92 98 461 467 I-clinical_variable
above 99 104 468 473 O
institutional 105 118 474 487 O
normal 119 125 488 494 O

Currently 0 9 495 504 O
receiving 10 19 505 514 O
any 20 23 515 518 O
investigational 24 39 519 534 B-treatment
agents 40 46 535 541 I-treatment

ECOG 0 4 542 546 B-clinical_variable
performance 5 16 547 558 I-clinical_variable
status 17 23 559 565 I-clinical_variable
of 24 26 566 568 O
0 27 28 569 570 B-lower_bound
or 29 31 571 573 O
1 32 33 574 575 B-upper_bound

Epithelioid 0 11 576 587 B-cancer
sarcoma 12 19 588 595 I-cancer

Fibrosarcoma 0 12 596 608 B-cancer

Histologically 0 14 609 623 O
confirmed 15 24 624 633 O
grade 25 30 634 639 B-lower_bound
2 31 32 640 641 I-lower_bound
or 33 35 642 644 O
3 36 37 645 646 B-upper_bound
soft 38 42 647 651 B-cancer
tissue 43 49 652 658 I-cancer
sarcoma 50 57 659 666 I-cancer
that 58 62 667 671 O
is 63 65 672 674 O
unresectable 66 78 675 687 O
or 79 81 688 690 O
metastatic 82 92 691 701 B-cancer

In 0 2 702 704 O
addition 3 11 705 713 O
, 11 12 713 714 O
these 13 18 715 720 O
patients 19 27 721 729 O
are 28 31 730 733 O
at 32 34 734 736 O
increased 35 44 737 746 O
risk 45 49 747 751 O
of 50 52 752 754 O
lethal 53 59 755 761 O
infections 60 70 762 772 O
when 71 75 773 777 O
treated 76 83 778 785 O
with 84 88 786 790 O
marrow 89 95 791 797 B-treatment
- 95 96 797 798 I-treatment
suppressive 96 107 798 809 I-treatment
therapy 108 115 810 817 I-treatment

Known 0 5 818 823 O
HIV 6 9 824 827 B-chronic_disease
- 9 10 827 828 O
positivity 10 20 828 838 O
on 21 23 839 841 O
combination 24 35 842 853 O
antiretroviral 36 50 854 868 B-treatment
therapy 51 58 869 876 I-treatment
because 59 66 877 884 O
of 67 69 885 887 O
the 70 73 888 891 O
potential 74 83 892 901 O
for 84 87 902 905 O
pharmacokinetic 88 103 906 921 B-treatment
interactions 104 116 922 934 I-treatment
with 117 121 935 939 I-treatment
dexrazoxane 122 133 940 951 I-treatment

Known 0 5 952 957 O
brain 6 11 958 963 B-cancer
metastases 12 22 964 974 I-cancer

Leiomyosarcoma 0 14 975 989 B-cancer

Leukocytes 0 10 990 1000 B-clinical_variable
≥ 11 12 1001 1002 O
3,000 13 18 1003 1008 B-lower_bound
/ 18 19 1008 1009 I-lower_bound
mcL 19 22 1009 1012 I-lower_bound

Liposarcoma 0 11 1013 1024 B-cancer
( 12 13 1025 1026 O
myxoid 13 19 1026 1032 B-cancer
/ 19 20 1032 1033 I-cancer
round 20 25 1033 1038 I-cancer
cell 26 30 1039 1043 I-cancer
, 30 31 1043 1044 O
pleomorphic 32 43 1045 1056 B-cancer
or 44 46 1057 1059 O
dedifferentiated 47 63 1060 1076 B-cancer
) 63 64 1076 1077 O

Malignant 0 9 1078 1087 B-cancer
fibrous 10 17 1088 1095 I-cancer
histiocytoma 18 30 1096 1108 I-cancer

Malignant 0 9 1109 1118 B-cancer
peripheral 10 20 1119 1129 I-cancer
nerve 21 26 1130 1135 I-cancer
sheath 27 33 1136 1142 I-cancer
tumor 34 39 1143 1148 I-cancer

Myocardial 0 10 1149 1159 B-chronic_disease
infarction 11 21 1160 1170 I-chronic_disease
within 22 28 1171 1177 O
the 29 32 1178 1181 O
past 33 37 1182 1186 B-upper_bound
12 38 40 1187 1189 I-upper_bound
months 41 47 1190 1196 I-upper_bound
, 47 48 1196 1197 O
or 49 51 1198 1200 O
stable 52 58 1201 1207 O
or 59 61 1208 1210 O
unstable 62 70 1211 1219 B-chronic_disease
angina 71 77 1220 1226 I-chronic_disease

Myxofibrosarcoma 0 16 1227 1243 B-cancer

Patient 0 7 1244 1251 O
must 8 12 1252 1256 O
have 13 17 1257 1261 O
a 18 19 1262 1263 O
negative 20 28 1264 1272 B-pregnancy
pregnancy 29 38 1273 1282 I-pregnancy
test 39 43 1283 1287 O
within 44 50 1288 1294 O
14 51 53 1295 1297 B-upper_bound
days 54 58 1298 1302 I-upper_bound
of 59 61 1303 1305 O
study 62 67 1306 1311 O
entry 68 73 1312 1317 O

Patients 0 8 1318 1326 O
with 9 13 1327 1331 O
the 14 17 1332 1335 O
following 18 27 1336 1345 O
tumor 28 33 1346 1351 B-cancer
types 34 39 1352 1357 O
are 40 43 1358 1361 O
eligible 44 52 1362 1370 O

Planning 0 8 1371 1379 O
to 9 11 1380 1382 O
initiate 12 20 1383 1391 O
treatment 21 30 1392 1401 B-treatment
with 31 35 1402 1406 I-treatment
doxorubicin 36 47 1407 1418 I-treatment
( 48 49 1419 1420 O
starting 49 57 1420 1428 O
dose 58 62 1429 1433 O
75 63 65 1434 1436 O
mg 66 68 1437 1439 O
/ 68 69 1439 1440 O
m2 69 71 1440 1442 O
) 71 72 1442 1443 O
as 73 75 1444 1446 O
routine 76 83 1447 1454 O
care 84 88 1455 1459 O

Platelets 0 9 1460 1469 B-clinical_variable
≥ 10 11 1470 1471 O
100,000 12 19 1472 1479 B-lower_bound
/ 19 20 1479 1480 I-lower_bound
mcl 20 23 1480 1483 I-lower_bound

Pregnant 0 8 1484 1492 B-pregnancy
and/or 9 15 1493 1499 O
breastfeeding 16 29 1500 1513 O

Prior 0 5 1514 1519 B-treatment
adjuvant 6 14 1520 1528 I-treatment
chemotherapy 15 27 1529 1541 I-treatment
with 28 32 1542 1546 I-treatment
gemcitabine 33 44 1547 1558 I-treatment
and/or 45 51 1559 1565 O
docetaxel 52 61 1566 1575 B-treatment
/ 61 62 1575 1576 O
paclitaxel 62 72 1576 1586 B-treatment
is 73 75 1587 1589 O
allowed 76 83 1590 1597 O

Prior 0 5 1598 1603 B-treatment
chemotherapy 6 18 1604 1616 I-treatment
for 19 22 1617 1620 O
advanced 23 31 1621 1629 O
or 32 34 1630 1632 O
metastatic 35 45 1633 1643 B-cancer
disease 46 53 1644 1651 I-cancer

Prior 0 5 1652 1657 O
or 6 8 1658 1660 O
second 9 15 1661 1667 B-cancer
primary 16 23 1668 1675 I-cancer
malignancies 24 36 1676 1688 I-cancer
within 37 43 1689 1695 O
the 44 47 1696 1699 O
last 48 52 1700 1704 B-upper_bound
two 53 56 1705 1708 I-upper_bound
years 57 62 1709 1714 I-upper_bound
( 63 64 1715 1716 O
except 64 70 1716 1722 O
carcinoma 71 80 1723 1732 B-cancer
in 81 83 1733 1735 I-cancer
situ 84 88 1736 1740 I-cancer
of 89 91 1741 1743 I-cancer
the 92 95 1744 1747 I-cancer
cervix 96 102 1748 1754 I-cancer
, 102 103 1754 1755 O
non 104 107 1756 1759 O
- 107 108 1759 1760 O
metastatic 108 118 1760 1770 O
prostate 119 127 1771 1779 B-cancer
cancer 128 134 1780 1786 I-cancer
, 134 135 1786 1787 O
or 136 138 1788 1790 O
basal 139 144 1791 1796 B-cancer
cell 145 149 1797 1801 I-cancer
or 150 152 1802 1804 O
squamous 153 161 1805 1813 B-cancer
cell 162 166 1814 1818 I-cancer
carcinoma 167 176 1819 1828 I-cancer
of 177 179 1829 1831 I-cancer
the 180 183 1832 1835 I-cancer
skin 184 188 1836 1840 I-cancer
which 189 194 1841 1846 O
were 195 199 1847 1851 O
treated 200 207 1852 1859 O
with 208 212 1860 1864 O
local 213 218 1865 1870 B-treatment
resection 219 228 1871 1880 I-treatment
only 229 233 1881 1885 O

Prior 0 5 1886 1891 B-treatment
treatment 6 15 1892 1901 I-treatment
with 16 20 1902 1906 I-treatment
anthracyclines 21 35 1907 1921 I-treatment

Should 0 6 1922 1928 O
a 7 8 1929 1930 O
woman 9 14 1931 1936 B-gender
become 15 21 1937 1943 B-pregnancy
pregnant 22 30 1944 1952 I-pregnancy
or 31 33 1953 1955 O
suspect 34 41 1956 1963 O
she 42 45 1964 1967 O
is 46 48 1968 1970 O
pregnant 49 57 1971 1979 O
while 58 63 1980 1985 O
participating 64 77 1986 1999 O
in 78 80 2000 2002 O
this 81 85 2003 2007 O
study 86 91 2008 2013 O
, 91 92 2013 2014 O
she 93 96 2015 2018 O
must 97 101 2019 2023 O
inform 102 108 2024 2030 O
her 109 112 2031 2034 O
treating 113 121 2035 2043 O
physician 122 131 2044 2053 O
immediately 132 143 2054 2065 O

Soft 0 4 2066 2070 B-cancer
tissue 5 11 2071 2077 I-cancer
sarcoma 12 19 2078 2085 I-cancer
for 20 23 2086 2089 O
which 24 29 2090 2095 O
treatment 30 39 2096 2105 B-treatment
with 40 44 2106 2110 I-treatment
an 45 47 2111 2113 I-treatment
anthracycline 48 61 2114 2127 I-treatment
is 62 64 2128 2130 O
appropriate 65 76 2131 2142 O
at 77 79 2143 2145 O
the 80 83 2146 2149 O
approval 84 92 2150 2158 O
of 93 95 2159 2161 O
the 96 99 2162 2165 O
Principal 100 109 2166 2175 O
Investigator 110 122 2176 2188 O
( 123 124 2189 2190 O
PI 124 126 2190 2192 O
) 126 127 2192 2193 O

Surgery 0 7 2194 2201 B-treatment
for 8 11 2202 2205 O
primary 12 19 2206 2213 O
or 20 22 2214 2216 O
metastatic 23 33 2217 2227 B-cancer
disease 34 41 2228 2235 I-cancer
after 42 47 2236 2241 O
chemotherapy 48 60 2242 2254 B-treatment
following 61 70 2255 2264 O
a 71 72 2265 2266 O
response 73 81 2267 2275 O
is 82 84 2276 2278 O
allowed 85 92 2279 2286 O

Symptomatic 0 11 2287 2298 O
valvular 12 20 2299 2307 B-chronic_disease
heart 21 26 2308 2313 I-chronic_disease
disease 27 34 2314 2321 I-chronic_disease

Synovial 0 8 2322 2330 B-cancer
sarcoma 9 16 2331 2338 I-cancer

Systolic 0 8 2339 2347 B-chronic_disease
heart 9 14 2348 2353 I-chronic_disease
failure 15 22 2354 2361 I-chronic_disease
defined 23 30 2362 2369 O
as 31 33 2370 2372 O
left 34 38 2373 2377 B-clinical_variable
ventricular 39 50 2378 2389 I-clinical_variable
ejection 51 59 2390 2398 I-clinical_variable
fraction 60 68 2399 2407 I-clinical_variable
≤ 69 70 2408 2409 O
45 71 73 2410 2412 B-upper_bound
% 73 74 2412 2413 I-upper_bound

Total 0 5 2414 2419 B-clinical_variable
bilirubin 6 15 2420 2429 I-clinical_variable
≤ 16 17 2430 2431 O
1.5 18 21 2432 2435 B-upper_bound
x 22 23 2436 2437 I-upper_bound
IULN 24 28 2438 2442 I-upper_bound

Unclassified 0 12 2443 2455 O
high 13 17 2456 2460 O
- 17 18 2460 2461 O
grade 18 23 2461 2466 O
sarcoma 24 31 2467 2474 B-cancer
( 32 33 2475 2476 O
not 33 36 2476 2479 O
otherwise 37 46 2480 2489 O
specified 47 56 2490 2499 O
) 56 57 2499 2500 O

Uncontrolled 0 12 2501 2513 O
intercurrent 13 25 2514 2526 O
illness 26 33 2527 2534 O
including 34 43 2535 2544 O
, 43 44 2544 2545 O
but 45 48 2546 2549 O
not 49 52 2550 2553 O
limited 53 60 2554 2561 O
to 61 63 2562 2564 O
, 63 64 2564 2565 O
ongoing 65 72 2566 2573 O
or 73 75 2574 2576 O
active 76 82 2577 2583 B-chronic_disease
infection 83 92 2584 2593 I-chronic_disease
, 92 93 2593 2594 O
symptomatic 94 105 2595 2606 O
congestive 106 116 2607 2617 B-chronic_disease
heart 117 122 2618 2623 I-chronic_disease
failure 123 130 2624 2631 I-chronic_disease
, 130 131 2631 2632 O
or 132 134 2633 2635 O
psychiatric 135 146 2636 2647 B-chronic_disease
illness 147 154 2648 2655 I-chronic_disease
/ 154 155 2655 2656 I-chronic_disease
social 155 161 2656 2662 I-chronic_disease
situations 162 172 2663 2673 I-chronic_disease
that 173 177 2674 2678 O
would 178 183 2679 2684 O
limit 184 189 2685 2690 O
compliance 190 200 2691 2701 O
with 201 205 2702 2706 O
study 206 211 2707 2712 O
requirements 212 224 2713 2725 O

Undifferentiated 0 16 2726 2742 O
pleomorphic 17 28 2743 2754 B-cancer
sarcoma 29 36 2755 2762 I-cancer

Women 0 5 2763 2768 B-clinical_variable
of 6 8 2769 2771 O
childbearing 9 21 2772 2784 O
potential 22 31 2785 2794 O
and 32 35 2795 2798 O
men 36 39 2799 2802 O
must 40 44 2803 2807 O
agree 45 50 2808 2813 B-contraception_consent
to 51 53 2814 2816 I-contraception_consent
use 54 57 2817 2820 I-contraception_consent
adequate 58 66 2821 2829 I-contraception_consent
contraception 67 80 2830 2843 I-contraception_consent
( 81 82 2844 2845 O
hormonal 82 90 2845 2853 B-contraception_consent
or 91 93 2854 2856 O
barrier 94 101 2857 2864 B-contraception_consent
method 102 108 2865 2871 I-contraception_consent
of 109 111 2872 2874 I-contraception_consent
birth 112 117 2875 2880 I-contraception_consent
control 118 125 2881 2888 I-contraception_consent
, 125 126 2888 2889 O
abstinence 127 137 2890 2900 B-contraception_consent
) 137 138 2900 2901 O
prior 139 144 2902 2907 O
to 145 147 2908 2910 O
study 148 153 2911 2916 O
entry 154 159 2917 2922 O
and 160 163 2923 2926 O
for 164 167 2927 2930 O
the 168 171 2931 2934 O
duration 172 180 2935 2943 O
of 181 183 2944 2946 O
study 184 189 2947 2952 O
participation 190 203 2953 2966 O

measurable 0 10 2967 2977 O
disease 11 18 2978 2985 O
defined 19 26 2986 2993 O
as 27 29 2994 2996 O
lesions 30 37 2997 3004 O
that 38 42 3005 3009 O
can 43 46 3010 3013 O
be 47 49 3014 3016 O
accurately 50 60 3017 3027 O
measured 61 69 3028 3036 O
in 70 72 3037 3039 O
at 73 75 3040 3042 O
least 76 81 3043 3048 O
one 82 85 3049 3052 O
dimension 86 95 3053 3062 O
( 96 97 3063 3064 O
longest 97 104 3064 3071 O
diameter 105 113 3072 3080 O
to 114 116 3081 3083 O
be 117 119 3084 3086 O
recorded 120 128 3087 3095 O
) 128 129 3095 3096 O
as 130 132 3097 3099 O
≥ 133 134 3100 3101 O
10 135 137 3102 3104 B-lower_bound
mm 138 140 3105 3107 I-lower_bound
with 141 145 3108 3112 O
CT 146 148 3113 3115 B-treatment
scan 149 153 3116 3120 I-treatment
, 153 154 3120 3121 O
as 155 157 3122 3124 O
≥ 158 159 3125 3126 O
20 160 162 3127 3129 B-lower_bound
mm 163 165 3130 3132 I-lower_bound
by 166 168 3133 3135 O
chest 169 174 3136 3141 O
x 175 176 3142 3143 O
- 176 177 3143 3144 O
ray 177 180 3144 3147 O
, 180 181 3147 3148 O
or 182 184 3149 3151 O
≥ 185 186 3152 3153 O
10 187 189 3154 3156 O
mm 190 192 3157 3159 O
with 193 197 3160 3164 O
calipers 198 206 3165 3173 O
by 207 209 3174 3176 O
clinical 210 218 3177 3185 O
exam 219 223 3186 3190 O

prior 0 5 3191 3196 B-treatment
adjuvant 6 14 3197 3205 I-treatment
androgen 15 23 3206 3214 I-treatment
deprivation 24 35 3215 3226 I-treatment
therapy 36 43 3227 3234 I-treatment
in 44 46 3235 3237 O
the 47 50 3238 3241 O
case 51 55 3242 3246 O
of 56 58 3247 3249 O
prostate 59 67 3250 3258 B-cancer
cancer 68 74 3259 3265 I-cancer
is 75 77 3266 3268 O
permitted 78 87 3269 3278 O
, 87 88 3278 3279 O
but 89 92 3280 3283 O
current 93 100 3284 3291 O
adjuvant 101 109 3292 3300 O
androgen 110 118 3301 3309 O
deprivation 119 130 3310 3321 O
therapy 131 138 3322 3329 O
is 139 141 3330 3332 O
not 142 145 3333 3336 O
) 145 146 3336 3337 O

